402 related articles for article (PubMed ID: 22009521)
1. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
Stoker AK; Olivier B; Markou A
Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
Jackson A; Papke RL; Damaj MI
Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
[TBL] [Abstract][Full Text] [Related]
3. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit.
Salas R; Pieri F; De Biasi M
J Neurosci; 2004 Nov; 24(45):10035-9. PubMed ID: 15537871
[TBL] [Abstract][Full Text] [Related]
4. Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.
Stoker AK; Marks MJ; Markou A
Eur J Pharmacol; 2015 Apr; 753():146-50. PubMed ID: 25107281
[TBL] [Abstract][Full Text] [Related]
5. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.
Stoker AK; Olivier B; Markou A
Psychopharmacology (Berl); 2012 May; 221(2):317-27. PubMed ID: 22147259
[TBL] [Abstract][Full Text] [Related]
6. The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse.
Jackson KJ; Sanjakdar SS; Muldoon PP; McIntosh JM; Damaj MI
Neuropharmacology; 2013 Jul; 70():228-35. PubMed ID: 23416040
[TBL] [Abstract][Full Text] [Related]
7. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit.
Salas R; Main A; Gangitano D; De Biasi M
Neuropharmacology; 2007 Dec; 53(7):863-9. PubMed ID: 17920082
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in cholinergic systems in the interpeduncular nucleus following nicotine exposure and withdrawal.
Correa VL; Flores RJ; Carcoba LM; Arreguin MC; O'Dell LE
Neuropharmacology; 2019 Nov; 158():107714. PubMed ID: 31325431
[TBL] [Abstract][Full Text] [Related]
10. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies.
Johnson PM; Hollander JA; Kenny PJ
Pharmacol Biochem Behav; 2008 Sep; 90(3):409-15. PubMed ID: 18466962
[TBL] [Abstract][Full Text] [Related]
11. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Ortiz NC; O'Neill HC; Marks MJ; Grady SR
Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
[TBL] [Abstract][Full Text] [Related]
12. β4-Nicotinic Receptors Are Critically Involved in Reward-Related Behaviors and Self-Regulation of Nicotine Reinforcement.
Husson M; Harrington L; Tochon L; Cho Y; Ibañez-Tallon I; Maskos U; David V
J Neurosci; 2020 Apr; 40(17):3465-3477. PubMed ID: 32184221
[TBL] [Abstract][Full Text] [Related]
13. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC
Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462
[TBL] [Abstract][Full Text] [Related]
14. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.
Stoker AK; Semenova S; Markou A
Neuropharmacology; 2008 Jun; 54(8):1223-32. PubMed ID: 18452957
[TBL] [Abstract][Full Text] [Related]
15. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
[TBL] [Abstract][Full Text] [Related]
16. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.
Jackson KJ; Martin BR; Changeux JP; Damaj MI
J Pharmacol Exp Ther; 2008 Apr; 325(1):302-12. PubMed ID: 18184829
[TBL] [Abstract][Full Text] [Related]
17. Tobacco smoke exposure induces nicotine dependence in rats.
Small E; Shah HP; Davenport JJ; Geier JE; Yavarovich KR; Yamada H; Sabarinath SN; Derendorf H; Pauly JR; Gold MS; Bruijnzeel AW
Psychopharmacology (Berl); 2010 Jan; 208(1):143-58. PubMed ID: 19936715
[TBL] [Abstract][Full Text] [Related]
18. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
Watkins SS; Stinus L; Koob GF; Markou A
J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
[TBL] [Abstract][Full Text] [Related]
19. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
Harris AC; Manbeck KE; Schmidt CE; Shelley D
Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410
[TBL] [Abstract][Full Text] [Related]
20. The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice.
Jackson AB; Toma W; Contreras KM; Alkhlaif Y; Damaj MI
Pharmacol Biochem Behav; 2019 Aug; 183():1-5. PubMed ID: 31145916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
